Diarylethylamines produces 8 documented subjective effects across 2 categories.
Full Diarylethylamines profileThe diarylethylamine class, including diphenidine, ephenidine, and methoxphenidine, represents a structurally distinct family of NMDA receptor antagonist dissociatives. Their shared experiential signature differs meaningfully from both the ketamine and PCP families.
The general diarylethylamine experience is characterized by a slow onset, typically one to two hours, followed by a progressive, deepening dissociation that unfolds over an extended duration. The dissociation has a characteristically dark, dreamlike quality, with a sense of slipping into a waking dream rather than being cleanly separated from reality. Physical numbness develops gradually, and the visual field often takes on a tunnel-like or darkened quality.
Cognitive effects tend toward abstract, philosophical ideation with a somewhat flat emotional tone. The stimulation level is moderate, sitting between the sedation of ketamine and the mania of PCP. Duration is typically long, six to ten hours, with protracted aftereffects. The class is notable for its tendency to produce amnesia at higher doses and for a general absence of the warmth and euphoria that characterize more popular dissociatives. Physical safety concerns include the long duration, which can make dosing errors particularly consequential.
A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a forceful, rapid pounding felt throughout the chest, neck, and temples. This effect is among the most commonly reported physiological responses to psychoactive substances and often accompanies stimulation, anxiety, or physical exertion during intoxication.
Pain reliefA suppression of negative physical sensations such as aches and pains, ranging from dulled awareness of discomfort to complete inability to perceive pain.
SedationA state of deep physical and mental calming that manifests as a progressive desire to remain still, lie down, and eventually drift toward sleep. Sedation ranges from a gentle drowsy relaxation to a heavy, irresistible pull into unconsciousness where maintaining wakefulness becomes a losing battle against the body's insistence on shutdown.
StimulationA state of heightened physical and mental energy characterized by increased wakefulness, elevated motivation, and a subjective sense of vigor that pervades both body and mind. Users often report feeling electrically alive, with a buzzing readiness to move, talk, and engage that can range from a pleasant caffeine-like lift to an overwhelming, jittery compulsion to act.
A complete or partial inability to form new memories or recall existing ones during and after substance use, ranging from minor gaps in recollection to total blackouts encompassing hours of experience.
Compulsive redosingAn overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maintain or intensify its effects, often overriding rational judgment and self-control.
ManiaAbnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated with stimulant use and certain drug interactions.
PsychosisPsychosis is a serious psychiatric state involving a fundamental break from consensus reality — characterized by firmly held false beliefs (delusions), perception of things that are not there (hallucinations), disorganized thought and speech, and a loss of the ability to distinguish internal mental events from external reality.
Diarylethylamines can produce 4 physical effects including stimulation, pain relief, increased heart rate, sedation.
Diarylethylamines produces 4 cognitive effects including compulsive redosing, amnesia, mania, psychosis.